Colossal Biosciences secures an additional $120M in funding for species expansion, bringing its Series C total to $320M. This funding includes participation from USIT, Bob Nelsen, and Peter Jackson.
Amount Raised
$120 Million
Round Type
Series C
AustinBiotechnologyInvestors
Description
Colossal Biosciences announces significant advancements in dodo de-extinction, securing an additional $120M in new funding. This funding allows for the expansion of their Avian Genetics Group and the establishment of key genomic resources. The company has raised over $555M in total funding since its inception. The latest capital brings the company's valuation to $10.32 billion.
Quick answer
Colossal Biosciences raised $120 Million in a Series C round, dated September 17, 2025. Investors: Peter Jackson, Bob Nelsen and Usit. Colossal Biosciences is based in Austin, Texas, United States.
- How much did Colossal Biosciences raise?
- Colossal Biosciences raised $120 Million in a Series C round on September 17, 2025.
- Who invested in Colossal Biosciences?
- Peter Jackson, Bob Nelsen and Usit are named as investors in this round.
- What does Colossal Biosciences do?
- Colossal was founded by emerging technology and software entrepreneur Ben Lamm and world-renowned geneticist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the..
- Where is Colossal Biosciences based and how big is it?
- Colossal Biosciences is based in Austin, Texas, United States. Fundz records about 174 employees.
- Who are the decision-makers at Colossal Biosciences?
- Fundz holds 1 contact at Colossal Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Colossal Biosciences that raised within 45 days of this round, from Fundz verified event records.
- MyndTec raised $38K on October 31, 2025.
- Altrove raised $10M (Seed) on October 31, 2025.
- Creative Medical Technology Holdings raised $4.2M (Funding Round) on October 31, 2025.
- Intensity Therapeutics raised $4M (Post-IPO Equity) on October 31, 2025.
- PACT raised $21M (Series A) on October 31, 2025.
- Zetagen Therapeutics raised $13M on October 31, 2025.
Who to call at Colossal Biosciences, and when
A new round usually means Colossal Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Colossal Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Colossal Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Colossal Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Colossal Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Colossal Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.